3 Factor Indexing’s AbbVie ABBV Stock Holding History

3 Factor Indexing’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$102K	Hold	406	–	–	0.09%	68
2026 Q1	$88.3K	Buy	+406	New	+$90.1K	0.08%	71

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

3 Factor Indexing's ABBV Position: Q2 2026 in Review

3 Factor Indexing held its AbbVie (ABBV) position steady in Q2 2026 at 406 shares worth $102K. The position accounts for 0.09% of the portfolio, ranked #68.

3 Factor Indexing first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

3 Factor Indexing held 406 shares of AbbVie worth $102K as of Q2 2026.
3 Factor Indexing left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of 3 Factor Indexing's portfolio in Q2 2026, its #68 holding.
3 Factor Indexing first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.